Us Bancorp \De\ Abb Vie Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Abb Vie Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 2,533,010 shares of ABBV stock, worth $429 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

2,533,010

Previous 2,554,729 0.85%

Holding current value

$429 Million

Previous $438 Million 14.16%

% of portfolio

0.65%

Previous 0.6%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $3.56 Million - $4.33 Million	-21,719 Reduced 0.85%	2,533,010 $500 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $6.08 Million - $7.1 Million	-39,252 Reduced 1.51%	2,554,729 $438 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $1.93 Million - $2.2 Million	-12,099 Reduced 0.46%	2,593,981 $472 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $1.81 Million - $2.04 Million	-13,174 Reduced 0.5%	2,606,080 $404 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $4.59 Million - $5.31 Million	34,364 Added 1.33%	2,619,254 $390 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $3.59 Million - $4.47 Million	-27,106 Reduced 1.04%	2,584,890 $348 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $1.92 Million - $2.21 Million	13,258 Added 0.51%	2,611,996 $416 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $6.47 Million - $7.76 Million	46,786 Added 1.83%	2,598,738 $420 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $4.54 Million - $5.2 Million	-33,801 Reduced 1.31%	2,551,952 $342 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $368,546 - $468,542	-2,678 Reduced 0.1%	2,585,753 $396 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $3.51 Million - $4.35 Million	-26,588 Reduced 1.02%	2,588,431 $420 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $454,106 - $574,576	4,227 Added 0.16%	2,615,019 $354 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $1.45 Million - $1.65 Million	13,670 Added 0.53%	2,610,792 $282 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $6.4 Million - $7.13 Million	-60,814 Reduced 2.29%	2,597,122 $293 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $3.47 Million - $3.81 Million	-33,871 Reduced 1.26%	2,657,936 $288 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $1.45 Million - $1.96 Million	-18,057 Reduced 0.67%	2,691,807 $288 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $870,440 - $1.02 Million	-10,132 Reduced 0.37%	2,709,864 $237 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $9.67 Million - $12.9 Million	-131,752 Reduced 4.62%	2,719,996 $267 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $1.7 Million - $2.57 Million	-26,306 Reduced 0.91%	2,851,748 $217 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $14.7 Million - $18.5 Million	-204,445 Reduced 6.63%	2,878,054 $255 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $6.85 Million - $8.24 Million	-108,824 Reduced 3.41%	3,082,499 $233 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $3.54 Million - $4.53 Million	53,921 Added 1.72%	3,191,323 $232 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $5.67 Million - $6.67 Million	-73,447 Reduced 2.29%	3,137,402 $253 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $29.3 Million - $36.2 Million	376,886 Added 13.3%	3,210,849 $296 Million
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $1.36 Million - $1.52 Million	15,349 Added 0.54%	2,833,963 $268 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $3.23 Million - $3.83 Million	-36,031 Reduced 1.26%	2,818,614 $261 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $6.22 Million - $8.33 Million	-67,631 Reduced 2.31%	2,854,645 $270 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $131,563 - $144,270	-1,469 Reduced 0.05%	2,922,276 $283 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $204 Million - $261 Million	2,923,745	2,923,745 $260 Million

Others Institutions Holding ABBV

# of Institutions

3,863

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $299B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account